Similarly, blocking of a subset of TAMs positive for C3AR1, CXCR4, and CSFR1, using either anti-C3a therapy or SB290157 treatment of B16 melanoma mice, resulted in reduced F4/80 infiltration as well as slowed tumor growth (48). The gene discussed is CXCR4; the disease is neoplasm.